Enoxaparin Sodium: A Comprehensive Guide to its Pharmaceutical Applications and Benefits
Discover the crucial role of Enoxaparin Sodium in preventing and treating thromboembolic disorders with detailed insights.
Get a Quote & SampleProduct Core Value
Enoxaparin Sodium Powder
Enoxaparin Sodium is a vital low molecular weight heparin (LMWH) renowned for its potent antithrombotic properties. Derived through controlled alkaline depolymerization, it primarily inhibits Factor Xa, playing a critical role in preventing and treating various thromboembolic disorders, making it a cornerstone in cardiovascular pharmacotherapy.
- Explore the enoxaparin sodium mechanism of action, detailing its high-affinity binding to antithrombin III to potentiate Factor Xa inhibition.
- Understand the critical enoxaparin sodium cardiovascular applications, from DVT prophylaxis to managing acute coronary syndromes.
- Learn why enoxaparin sodium powder for injection is favored for its predictable pharmacokinetic profile and sustained anticoagulant activity.
- Discover the importance of enoxaparin sodium USP BP compliant standards, ensuring high purity and efficacy for pharmaceutical use.
Key Advantages
Targeted Anticoagulation
Benefit from the selective inhibition of Factor Xa by enoxaparin sodium, leading to effective anticoagulation with a reduced risk of bleeding complications compared to unfractionated heparin.
Versatile Therapeutic Use
Leverage the broad utility of this antithrombotic agent in preventing and treating conditions like venous thromboembolism and managing acute coronary syndromes, as highlighted in the enoxaparin sodium treatment of acute coronary syndromes research.
Predictable Pharmacokinetics
Experience more consistent therapeutic outcomes due to the predictable pharmacokinetic profile of this low molecular weight heparin, essential for reliable patient management in various medical settings.
Key Applications
Venous Thromboembolism Prophylaxis
Essential for the enoxaparin sodium prophylaxis of DVT, this compound is crucial in preventing blood clots in patients at risk, particularly post-surgery or during prolonged immobility.
Acute Coronary Syndromes Management
A critical component in managing unstable angina and non-Q-wave myocardial infarctions, contributing to better patient outcomes in acute cardiovascular events.
Deep Vein Thrombosis Treatment
Effectively used in conjunction with warfarin for both inpatient and outpatient treatment of established DVT and pulmonary embolism, showcasing its role as a reliable pharmaceutical intermediate.
Myocardial Infarction Therapy
Demonstrates efficacy in reducing recurrent myocardial infarction and death in patients with STEMI when administered with aspirin, underscoring its importance in acute cardiac care.